Cargando…
Targeted photodynamic therapy selectively kills activated fibroblasts in experimental arthritis
OBJECTIVE: In RA, synovial fibroblasts become activated. These cells express fibroblast activation protein (FAP) and contribute to the pathogenesis by producing cytokines, chemokines and proteases. Selective depletion in inflamed joints could therefore constitute a viable treatment option. To this e...
Autores principales: | Dorst, Daphne N, Rijpkema, Mark, Boss, Marti, Walgreen, Birgitte, Helsen, Monique M A, Bos, Desirée L, Brom, Maarten, Klein, Christian, Laverman, Peter, van der Kraan, Peter M, Gotthardt, Martin, Koenders, Marije I, Buitinga, Mijke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7733717/ https://www.ncbi.nlm.nih.gov/pubmed/32734285 http://dx.doi.org/10.1093/rheumatology/keaa295 |
Ejemplares similares
-
Photodynamic Therapy Targeting Macrophages Using IRDye700DX-Liposomes Decreases Experimental Arthritis Development
por: Dorst, Daphne N., et al.
Publicado: (2021) -
Targeting of fibroblast activation protein in rheumatoid arthritis patients: imaging and ex vivo photodynamic therapy
por: Dorst, Daphne N, et al.
Publicado: (2021) -
Fibroblast Activation Protein Targeted Photodynamic Therapy Selectively Kills Activated Skin Fibroblasts from Systemic Sclerosis Patients and Prevents Tissue Contraction
por: Dorst, Daphne N., et al.
Publicado: (2021) -
Receptor-Targeted Photodynamic Therapy of Glucagon-Like Peptide 1 Receptor–Positive Lesions
por: Boss, Marti, et al.
Publicado: (2020) -
Systemic overexpression of interleukin-22 induces the negative immune-regulator SOCS3 and potently reduces experimental arthritis in mice
por: Aarts, Joyce, et al.
Publicado: (2020)